What are the causes of non-cirrhotic portal fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Non-Cirrhotic Portal Fibrosis

Non-cirrhotic portal fibrosis (NCPF) is primarily caused by obliterative portovenopathy leading to portal hypertension, with key etiologies including exposure to volatile chemicals, vascular disorders, and certain systemic conditions. 1, 2

Toxic and Chemical Exposures

  • Volatile chemicals: Exposure to industrial chemicals including:

    • Benzene
    • Xylene
    • Vinyl chloride monomer (VCM)
    • Copper sulfate (in vineyard sprays)
    • Nitrosamines (in rubber industry workers) 1
  • Mechanism: These toxicants can cause endothelial injury in sinusoids, leading to progressive periportal fibrosis without cirrhosis

Vascular Disorders

  • Porto-sinusoidal vascular disease: Characterized by portal vein obliteration with progressive periportal fibrosis 1
  • Sinusoidal obstruction syndrome (SOS): Results from endothelial injury in sinusoids, predominantly in centrolobular areas 1
  • Obliterative venopathy: Sclerosis and obliteration of small-sized portal vein radicles 2

Systemic Diseases and Conditions

  • Immunological disorders:

    • Systemic lupus erythematosus
    • Rheumatoid arthritis
    • Scleroderma 3
  • Hematological disorders:

    • Myeloproliferative disorders
    • Prothrombotic conditions
    • Antiphospholipid syndrome 4
  • Infectious causes: Chronic or recurrent bacterial infections, especially in developing countries 5, 6

Diagnostic Features

Portal hypertension in NCPF is characterized by:

  • Patent portal and hepatic veins
  • Absence of cirrhosis on liver biopsy
  • Preserved liver function
  • Low liver stiffness measurement by transient elastography (<12 kPa) 4

Histopathological Findings

  • Maintained lobular architecture
  • Portal fibrosis of variable degree
  • Sclerosis and obliteration of small portal vein radicles
  • Subcapsular scarring with collapse of underlying parenchyma
  • Absence of piecemeal or hepatocytic necrosis 2

Clinical Presentation

  • Massive splenomegaly
  • Anemia (often due to hypersplenism)
  • Well-tolerated episodes of variceal bleeding
  • Preserved liver function
  • Rare occurrence of jaundice, ascites, or hepatic encephalopathy 2, 5

Special Considerations

  • More common in developing countries, particularly India
  • Typically affects young adults from lower socioeconomic backgrounds
  • Has better prognosis compared to cirrhotic portal hypertension
  • May develop spontaneous portosystemic shunts (splenorenal or umbilical) which can protect against variceal bleeding 2

Late Manifestations

  • Some patients may progress to nodular transformation with abnormal liver function
  • Features similar to incomplete septal cirrhosis may develop in advanced stages 2

NCPF remains a diagnosis of exclusion requiring the definite absence of liver cirrhosis and extrahepatic portal vein obstruction, with clinical evidence of portal hypertension.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liver Disease and Splenomegaly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-cirrhotic portal fibrosis: current concepts and management.

Journal of gastroenterology and hepatology, 2002

Research

Non-cirrhotic portal fibrosis.

Journal of gastroenterology and hepatology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.